Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Alibaba Shares Fall as AI Spending Hits Profit 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
Samsung Shares Rise on $72 Billion Shareholder Return Plan 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Add as a preferred source on Google
SAN DIEGO, May 04, 2018 -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it plans to release its first quarter 2018 financial results after the market closes on Thursday, May 10, 2018. The company will hold a conference call and simultaneous webcast at 5:00 PM, Eastern Time (2:00 PM Pacific Time) on Thursday, May 10, 2018 to discuss the company's financial results and provide a business update. Interested parties may access the conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934 (international) using passcode 3693617. Media and individuals will be in a listen-only mode. Participants are asked to dial in a few minutes prior to the call to register for the event. The conference call will also be webcast live at: https://edge.media-server.com/m6/p/q4jkh9dx.
An archive of the webcast will be available for twelve months following the event on the Obalon Therapeutics website located at http://investor.obalon.com in the “News & Events” section.
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:
William Plovanic
Chief Financial Officer
Obalon Therapeutics, Inc.
Office: +1 760 607 5103
[email protected]
Media:
Megan Driscoll
EvolveMKD
Office Phone: +1 646 517 4220
[email protected]
